An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

NCT00374166 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

325

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety Disorders

Interventions

DRUG: SSR149415
DRUG: Placebo
DRUG: Paroxetine

Sponsor

Sanofi